Cong Tang

Cong Tang

Auto-generated profile, based on publicly available information

Cong Tang

GIMM - Gulbenkian Institute for Molecular Medicine, Avenida Prof. Egas Moniz, Lisboa 1649-028, Portugal

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2024 in Nature
Verified
Journal Article
Open access
PDF file
BHBuwei Huang
Buwei Huang
MAMohamad Abedi
Mohamad Abedi
GAGreen Ahn
Green Ahn
BCBrian Coventry
Brian Coventry
ISIsaac Sappington
Isaac Sappington
DBDavid Baker
David Baker
Endocytosis and lysosomal trafficking of cell surface receptors can be triggered by endogenous ligands. Therapeutic approaches such as lysosome-targeting chimaeras1,2 (LYTACs) and cytokine receptor-targeting chimeras3 (KineTACs) have used this to target specific proteins for degradation by fusing modified native ligands to target binding proteins. Although powerful, these approaches can be limited by competition with native ligands and requirements for chemical modification that limit genetic encodability and can complicate manufacturing, and, more generally, there may be no native ligands that stimulate endocytosis through a given receptor. Here we describe computational design approaches for endocytosis-triggering binding proteins (EndoTags) that overcome these challenges. We present EndoTags for insulin-like growth factor 2 receptor (IGF2R) and asialoglycoprotein receptor (ASGPR), sortilin and transferrin receptors, and show that fusing these tags to soluble or transmembrane target protein binders leads to lysosomal trafficking and target degradation. As these receptors have different tissue distributions, the different EndoTags could enable targeting of degradation to different tissues. EndoTag fusion to a PD-L1 antibody considerably increases efficacy in a mouse tumour model compared to antibody alone. The modularity and genetic encodability of EndoTags enables AND gate control for higher-specificity targeted degradation, and the localized secretion of degraders from engineered cells. By promoting endocytosis, EndoTag fusion increases signalling through an engineered ligand–receptor system by nearly 100-fold. EndoTags have considerable therapeutic potential as targeted degradation inducers, signalling activators for endocytosis-dependent pathways, and cellular uptake inducers for targeted antibody–drug and antibody–RNA conjugates.

4 May 2022 in Cell
Verified
Journal Article
Closed access
XMXiulei Mo
Xiulei Mo
QNQiankun Niu
Qiankun Niu
AIAndrey A. Ivanov
Andrey A. Ivanov
YTYiu Huen Tsang
Yiu Huen Tsang
CTCong Tang
Cong Tang
HFHaian Fu
Haian Fu

1 March 2019 in Cell Chemical Biology
Verified
Journal Article
Closed access
XMXiulei Mo
Xiulei Mo
CTCong Tang
Cong Tang
QNQiankun Niu
Qiankun Niu
TMTingxuan Ma
Tingxuan Ma
YDYuhong Du
Yuhong Du
HFHaian Fu
Haian Fu

1 May 2021 in Cell Chemical Biology
Verified
Journal Article
Closed access
CTCong Tang
Cong Tang
XMXiulei Mo
Xiulei Mo
QNQiankun Niu
Qiankun Niu
AWAlafate Wahafu
Alafate Wahafu
XYXuan Yang
Xuan Yang
HFHaian Fu
Haian Fu

25 July 2019 in Oncology Reports
Verified
Journal Article
Open access
PDF file
CTCong Tang
Cong Tang
TLTianjie Liu
Tianjie Liu
KWKe Wang
Ke Wang
XWXinyang Wang
Xinyang Wang
SXShan Xu
Shan Xu
Jin ZengJin Zeng
Jin Zeng
Hypoxia is a tumorigenesis-related microenvironment change which usually occurs in the earliest stage of prostate cancer (PCa) development. Accumulating evidence has demonstrated that hypoxia/hypoxia-inducing factor (HIF) is involved in the induction of epithelial-mesenchymal transition (EMT) and increased metastatic potential in PCa. However, the mechanism by which hypoxia/HIF regulates EMT remains unclear. In the present study, we demonstrated the molecular mechanisms of hypoxia-induced EMT in PCa, focusing on HIF-1 alpha/Forkhead box M1 (FoxM1) signaling pathway. PCa PC3 and DU145 cell lines were used as the model system in vitro. Our data revealed that hypoxia induced EMT in PCa cells. Bioinformatics analysis identified the possible association between HIF-1 alpha and FoxM1. Additionally, FoxM1 was significantly associated with PCa development and Gleason scores of PCa. Exposure to hypoxia resulted in the increased expression of HIF-1 alpha and FoxM1. Genetic knockdown FoxM1 abolished hypoxia-induced EMT in PCa, while exogenous overexpression of FoxM1 facilitated hypoxia-induced EMT. Furthermore, the increase of FoxM1 during hypoxia was due to the transcriptional regulation on the FoxM1 promoter by HIF-1 alpha. We also confirmed the binding site of HIF-1 alpha on the FoxM1 promoter by different lengths promoter sequences. These findings provide new insights into how EMT is regulated in PCa under hypoxic stress. It is worthwhile to investigate in future that inhibition of FoxM1 as a potential target may be an effective therapeutic strategy against PCa.

29 April 2019 in Current Stem Cell Research & Therapy
Verified
Journal Article
Closed access
PDF file
CTCong Tang
Cong Tang
GZGuodong Zhu
Guodong Zhu
The nuclear factor kappa B (NF-κB) consists of a family of transcription factors involved in the regulation of a wide variety of biological responses. Growing evidence support that NF-κB plays a major role in oncogenesis as well as its well-known function in the regulation of immune responses and inflammation. Therefore, we made a review of the diverse molecular mechanisms by which the NF-κB pathway is constitutively activated in different types of human cancers and the potential role of various oncogenic genes regulated by this transcription factor in cancer development and progression. We also discussed various pharmacological approaches employed to target the deregulated NF-κB signaling pathway and their possible therapeutic potential in cancer therapy. Moreover, Syk (Spleen tyrosine kinase), non-receptor tyrosine kinase which mediates signal transduction downstream of a variety of transmembrane receptors including classical immune-receptors like the B-cell receptor (BCR), which can also activate the inflammasome and NF-κB-mediated transcription of chemokines and cytokines in the presence of pathogens would be discussed as well. The highlight of this review article is to summarize the classic and novel signaling pathways involved in NF-κB and Syk signaling and then raise some possibilities for cancer therapy.